Targeting IFN-I driven tertiary lymphoid structures halts B cell-mediated bone loss in periodontitis

Jiawei Lu , Xiao Wu , Zehui Xiong , Jinyi Zhang , Haipeng Yang , Feng Liu , Lijun Luo

International Journal of Oral Science ›› 2026, Vol. 18 ›› Issue (1) : 53

PDF
International Journal of Oral Science ›› 2026, Vol. 18 ›› Issue (1) :53 DOI: 10.1038/s41368-026-00450-7
Article
research-article
Targeting IFN-I driven tertiary lymphoid structures halts B cell-mediated bone loss in periodontitis
Author information +
History +
PDF

Abstract

Lymphocytes play a central role in adaptive immunity and represent the primary source of RANKL in periodontitis. Understanding their organization and activation within gingiva is therefore essential. This study investigates the role of tertiary lymphoid structures (TLSs), ectopic lymphoid aggregates that orchestrate local immune responses. Using multiplex immunohistochemistry staining, we found that TLSs form and mature with increasing inflammatory severity. These structures function as hubs for B cell activation and were associated with poorer surgical outcomes. Given the known role of fibroblasts in initiating TLS assembly, we explored the underlying mechanism. Using single-cell RNA sequencing and in vitro assays, we identified that oral pathogens activate the IFN-I–IRF7 axis in gingival fibroblasts, leading to overproduction of IFNβ and driving their differentiation into a CXCL13-producing subtype that facilitates TLS organization. Furthermore, in a mouse periodontitis model, we demonstrated that activated IgD+CD80+ B cells within TLSs promote osteoclastogenesis and bone resorption via RANKL secretion. Therapeutically, inhibition of IFN-I signaling disrupted this pathogenic cascade by suppressing TLS formation and subsequent RANKL production, thereby mitigating periodontitis bone loss. In conclusion, our findings establish TLSs as pathological hubs that coordinate B cell-mediated bone destruction in periodontitis and highlight the IFN-I signaling pathway as a promising target for therapeutic intervention.

Cite this article

Download citation ▾
Jiawei Lu, Xiao Wu, Zehui Xiong, Jinyi Zhang, Haipeng Yang, Feng Liu, Lijun Luo. Targeting IFN-I driven tertiary lymphoid structures halts B cell-mediated bone loss in periodontitis. International Journal of Oral Science, 2026, 18 (1) : 53 DOI:10.1038/s41368-026-00450-7

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat. Rev. Dis. Prim., 2017, 3 17038

[2]

Gonzales JR. T- and B-cell subsets in periodontitis. Periodontol 2000, 2015, 69: 181-200

[3]

Baima G, Arce M, Romandini M, Van Dyke T. Inflammatory and immunological basis of periodontal diseases. J. Periodontal Res., 2025

[4]

Costalonga M, Thumbigere-Math V, Herzberg MC. Autoimmunity and periodontitis. J. Periodontal Res., 2026

[5]

Schumacher, T. N. & Thommen, D. S. Tertiary lymphoid structures in cancer. Science375, eabf9419 https://doi.org/10.1126/science.abf9419 (2022).

[6]

Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol., 2014, 14: 447-462

[7]

Corsiero, E. et al. Autoimmunity to stromal-derived autoantigens in rheumatoid ectopic germinal centers exacerbates arthritis and affects clinical response. J. Clin. Invest.134, https://doi.org/10.1172/jci169754 (2024).

[8]

Sato Y, et al. . Heterogeneous fibroblasts underlie age-dependent tertiary lymphoid tissues in the kidney. JCI Insight, 2016, 1 e87680

[9]

Adachi Y, et al. . Distinct germinal center selection at local sites shapes memory B cell response to viral escape. J. Exp. Med., 2015, 212: 1709-1723

[10]

Zhao L, et al. . Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct. Target Ther., 2024, 9: 225

[11]

Buckley CD, Barone F, Nayar S, Bénézech C, Caamaño J. Stromal cells in chronic inflammation and tertiary lymphoid organ formation. Annu Rev. Immunol., 2015, 33: 715-745

[12]

Fletcher AL, Acton SE, Knoblich K. Lymph node fibroblastic reticular cells in health and disease. Nat. Rev. Immunol., 2015, 15: 350-361

[13]

Wielento A, Lagosz-Cwik KB, Potempa J, Grabiec AM. The role of gingival fibroblasts in the pathogenesis of periodontitis. J. Dent. Res., 2023, 102: 489-496

[14]

Fazilleau N, Mark L, McHeyzer-Williams LJ, McHeyzer-Williams MG. Follicular helper T cells: lineage and location. Immunity, 2009, 30: 324-335

[15]

Joss A, Adler R, Lang NP. Bleeding on probing. A parameter for monitoring periodontal conditions in clinical practice. J. Clin. Periodontol., 1994, 21: 402-408

[16]

Lang NP, Adler R, Joss A, Nyman S. Absence of bleeding on probing. an indicator of periodontal stability. J. Clin. Periodontol., 1990, 17: 714-721

[17]

Williams DW, et al. . Human oral mucosa cell atlas reveals a stromal-neutrophil axis regulating tissue immunity. Cell, 2021, 184: 4090-4104.e4015

[18]

Denton AE, et al. . Type I interferon induces CXCL13 to support ectopic germinal center formation. J. Exp. Med., 2019, 216: 621-637

[19]

Rangel-Moreno J, et al. . The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol., 2011, 12: 639-646

[20]

Barone F, et al. . IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs. Proc. Natl. Acad. Sci. USA, 2015, 112: 11024-11029

[21]

Calame KL, Lin KI, Tunyaplin C. Regulatory mechanisms that determine the development and function of plasma cells. Annu Rev. Immunol., 2003, 21: 205-230

[22]

Zhang J, et al. . Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood, 2009, 113: 4586-4594

[23]

Yoshitomi H, Ueno H. Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases. Cell. Mol. Immunol., 2020, 18: 523-527

[24]

Komura K. CD19: a promising target for systemic sclerosis. Front Immunol., 2024, 15 1454913

[25]

Tomayko MM, Steinel NC, Anderson SM, Shlomchik MJ. Cutting edge: Hierarchy of maturity of murine memory B cell subsets. J. Immunol., 2010, 185: 7146-7150

[26]

Zuccarino-Catania GV, et al. . CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat. Immunol., 2014, 15: 631-637

[27]

Koelsch K, et al. . Mature B cells class switched to IgD are autoreactive in healthy individuals. J. Clin. Invest, 2007, 117: 1558-1565

[28]

Castleman MJ. Editorial: unswitched memory B cells in human health and disease. Front Immunol., 2024, 15 1455243

[29]

Yuuki H, Itamiya T, Nagafuchi Y, Ota M, Fujio K. B cell receptor repertoire abnormalities in autoimmune disease. Front Immunol., 2024, 15 1326823

[30]

Shi K, et al. . Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J. Immunol., 2001, 166: 650-655

[31]

Victora GD, Nussenzweig MC. Germinal centers. Annu. Rev. Immunol., 2022, 40: 413-442

[32]

Kurosaki T, Kometani K, Ise W. Memory B cells. Nat. Rev. Immunol., 2015, 15: 149-159

[33]

Kanematsu M, et al. . Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J. Bone Min. Res., 2000, 15: 1321-1329

[34]

Kawai T, et al. . B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol., 2006, 169: 987-998

[35]

Han Y, Jin Y, Miao Y, Shi T, Lin X. Improved RANKL expression and osteoclastogenesis induction of CD27+CD38− memory B cells: A link between B cells and alveolar bone damage in periodontitis. J. Periodontal Res., 2018, 54: 73-80

[36]

Calvani N, Silvestris F, Cafforio P, Dammacco F. Osteoclast-like cell formation by circulating myeloma B lymphocytes: role of RANK-L. Leuk. Lymphoma, 2004, 45: 377-380

[37]

Bingham CO3rd, et al. . Conversion of functional assessment of chronic illness therapy-fatigue to patient-reported outcomes measurement information system fatigue scores in two phase iii baricitinib rheumatoid arthritis trials. Arthritis Care Res. (Hoboken), 2021, 73: 481-488

[38]

Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat. Immunol., 2012, 13: 214-222

[39]

Marin ND, Dunlap MD, Kaushal D, Khader SA. Friend or Foe: the protective and pathological roles of inducible bronchus-associated lymphoid tissue in pulmonary diseases. J. Immunol., 2019, 202: 2519-2526

[40]

Silva-Sanchez A, Randall TD. Role of iBALT in respiratory immunity. Curr. Top. Microbiol Immunol., 2020, 426: 21-43

[41]

Qaiser T, et al. . Usability of deep learning and H&E images predict disease outcome-emerging tool to optimize clinical trials. npj Precis. Oncol., 2022, 6 37

[42]

Yan F, et al. . PathOrchestra: a comprehensive foundation model for computational pathology with over 100 diverse clinical-grade tasks. npj Digit. Med., 2025, 8 695

[43]

Papapanou PN, et al. . Periodontitis: consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J. Clin. Periodontol., 2018, 45: S162-s170

[44]

Huang H, et al. . Nanoparticulate cell-free DNA scavenger for treating inflammatory bone loss in periodontitis. Nat. Commun., 2022, 13 5925

[45]

Su S, et al. . Modulation of innate immune response to viruses including SARS-CoV-2 by progesterone. Signal Transduct. Target Ther., 2022, 7: 137

[46]

Zhang K, et al. . Inhibition of gingival fibroblast necroptosis mediated by RIPK3/MLKL attenuates periodontitis. J. Clin. Periodontol., 2023, 50: 1264-1279

[47]

Feng M, et al. . Arrestin beta-2 deficiency exacerbates periodontal inflammation by mediating activating transcription factor 6 activation and abnormal remodelling of the extracellular matrix. J. Clin. Periodontol., 2024, 51: 742-753

[48]

Liu J, et al. . Tertiary lymphoid structures are related to inflammatory progression and bone loss in human apical periodontitis. J. Endod., 2023, 49: 1138-1144

[49]

Bankhead P, et al. . QuPath: open source software for digital pathology image analysis. Sci. Rep., 2017, 7 16878

[50]

Schoumacher C, et al. . CD3-CD8 immune score associated with a clinical score stratifies PDAC prognosis regardless of adjuvant or neoadjuvant chemotherapy. Oncoimmunology, 2024, 13 2294563

[51]

Sato Y, et al. . Developmental stages of tertiary lymphoid tissue reflect local injury and inflammation in mouse and human kidneys. Kidney Int, 2020, 98: 448-463

[52]

Lynch, K. T. et al. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma. J. Immunother. Cancer9, https://doi.org/10.1136/jitc-2020-002273 (2021).

[53]

Sato, Y. et al. Stem-like CD4+ T cells in perivascular tertiary lymphoid structures sustain autoimmune vasculitis. Sci. Transl. Med.15, https://doi.org/10.1126/scitranslmed.adh0380 (2023).

[54]

Stuart T, et al. . Comprehensive integration of single-cell data. Cell, 2019, 177: 1888-1902.e1821

[55]

Aran D, et al. . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol., 2019, 20: 163-172

[56]

Aibar S, et al. . SCENIC: single-cell regulatory network inference and clustering. Nat. Methods, 2017, 14: 1083-1086

[57]

Pandiyan P, Bhaskaran N, Zhang Y, Weinberg A. Isolation of T cells from mouse oral tissues. Biol. Proced. Online, 2014, 16: 1-7

[58]

Mizraji G, Segev H, Wilensky A, Hovav A-H. Isolation, processing and analysis of murine gingival cells. J. Visualized Exp. JoVE, 2013, 77: e50388

[59]

Shen Z, et al. . Inhibition of CCL2 by bindarit alleviates diabetes-associated periodontitis by suppressing inflammatory monocyte infiltration and altering macrophage properties. Cell. Mol. Immunol., 2021, 18: 2224-2235

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82071123)

RIGHTS & PERMISSIONS

The Author(s)

PDF

8

Accesses

0

Citation

Detail

Sections
Recommended

/